NZX Governance Explorer

How Promisia Healthcare Limited makes money

Where PHL’s revenue went in FY2021: operating costs, depreciation, interest and tax, and what was left as net profit. Built from the income statement in the filed annual report, and drawn only when the figures reconcile with each other. PHL company profile

How Promisia Healthcare Limited makes money — FY2021

Revenue $6.1m · EBITDA $1.0m (16.8% of revenue) · Net profit $26k (0.4% of revenue) · Financial year ending March (from the issuer record)

Promisia Healthcare Limited (PHL) FY2021: where revenue of $6.1m wentRevenue → EBITDA: $1.0mRevenue → Operating costs (net of other income): $5.0mEBITDA → EBIT: $639kEBITDA → Depreciation & amortisation: $377kEBIT → Net profit: $26kEBIT → Interest: $613kIncome tax credit → Interest: $281kRevenue: $6.1mRevenue$6.1mEBITDA: $1.0mEBITDA$1.0mOperating costs (net of other income): $5.0m (derived)Operating costs (net ofother income)$5.0m · derivedEBIT: $639kEBIT$639kDepreciation & amortisation: $377kDepreciation &amortisation$377kIncome tax credit: $281kIncome tax credit$281kNet profit: $26kNet profit$26kInterest: $894kInterest$894k

Band widths are proportional to NZD amounts. Dashed outlines mark derived figures; the hatched node is a balancing item (net profit less every line above it).

Promisia Healthcare Limited FY2021 figures used in the chart
FY2021AmountStatusNote
Revenue$6.1mReported
Operating costs (net of other income)−$5.0mDerived *Reported operating expenses $4.6m do not reconcile; not used.
EBITDA$1.0mReported
Depreciation & amortisation−$377kReported
EBIT$639kReported
Interest (net finance costs)−$894kReported
Income tax credit+$281kReported
Other items (net gain)+$0Balancing item *Net profit less the lines above; covers fair-value movements, impairments, associates and anything else not itemised.
Net profit$26kReported
  • * operating costs: $5.0m = Revenue − EBITDA
Checks run on these figures (6)
  • Passed: Revenue is within the scale of a column stored in thousands.
  • Passed: Revenue in the income statement ($6.1m) vs the summary table ($6.1m): agree within 2%.
  • Passed: EBITDA − D&A = $0.6m vs reported EBIT $0.6m: reconciles.
  • Not met: Reported operating expenses ($4.6m) leave $1.5m, not EBITDA of $1m (gap $0.5m); costs derived as revenue minus operating profit instead. No split is shown.
  • Passed: Balancing item $0m is 0.0% of revenue (limit 25%).
  • Not met: No operating segments recorded for this year.

Figures extracted automatically from the annual report; check against the report. NZD thousands as stored, shown in millions. Source: annual_report_pdf · method: claude_haiku_pdf · extracted 7 March 2026.

Annual report: FY21 Annual Report for the 15 months ended 31 March 2021 (PDF, NZX)

Year-on-year EBITDA bridge (FY2020 → FY2021)

Bridge not available: there is no FY2020 annual statement on file to compare with.

Margins over time

EBITDA, EBIT and net profit as a share of revenue for each year whose figures passed the checks (5 of 9 years from FY2017). The shaded line is the median of 11 other listed Healthcare operating companies, using each one’s same financial year where it passed the checks; the number of companies in each median is in the table. Gaps are years that were not charted.

EBITDA margin
PHL ebitda margin by financial year, with peer median0%20%40%FY17FY18FY20FY22FY24FY25FY2017: not charted — operating lossFY2018: not charted — operating lossFY2019: not charted — operating lossFY2020: not charted — no annual statement on fileFY2021: PHL 16.8%; peer median 19.1% (3)FY2022: PHL 23.7%; peer median 22.4% (4)FY2023: PHL 15.0%; peer median 11.4% (5)FY2024: PHL 13.8%; peer median 12.2% (7)FY2025: PHL 13.5%; peer median 13.2% (7)
EBIT margin
PHL ebit margin by financial year, with peer median0%20%40%FY17FY18FY20FY22FY24FY25FY2017: not charted — operating lossFY2018: not charted — operating lossFY2019: not charted — operating lossFY2020: not charted — no annual statement on fileFY2021: PHL 10.5%; peer median 9.5% (5)FY2022: PHL 19.4%; peer median 18.3% (4)FY2023: PHL 11.5%; peer median 6.9% (5)FY2024: PHL 10.8%; peer median 6.4% (7)FY2025: PHL 12.2%; peer median 8.8% (7)
Net margin
PHL net margin by financial year, with peer median0%20%40%FY17FY18FY20FY22FY24FY25FY2017: not charted — operating lossFY2018: not charted — operating lossFY2019: not charted — operating lossFY2020: not charted — no annual statement on fileFY2021: PHL 0.4%; peer median 3.7% (5)FY2022: PHL 10.7%; peer median 13.7% (4)FY2023: PHL 2.9%; peer median 6.2% (5)FY2024: PHL 6.2%; peer median 3.1% (7)FY2025: PHL 22.0%; peer median 5.5% (7)

PHL   peer median   below the axis: year not charted (reason in the table). All panels share one scale.

PHL margins by year with peer medians
YearEBITDA margin: PHL · peer median (n)EBIT margin: PHL · peer median (n)Net margin: PHL · peer median (n)Note
FY2017—— (1)—33.0% (2)—22.5% (2)Not charted: operating loss
FY2018—8.6% (3)—16.6% (4)—11.6% (4)Not charted: operating loss
FY2019—11.7% (4)—7.2% (5)—3.9% (5)Not charted: operating loss
FY2020—9.3% (4)—12.8% (6)—7.9% (6)Not charted: no annual statement on file
FY202116.8%19.1% (3)10.5%9.5% (5)0.4%3.7% (5)
FY202223.7%22.4% (4)19.4%18.3% (4)10.7%13.7% (4)
FY202315.0%11.4% (5)11.5%6.9% (5)2.9%6.2% (5)
FY202413.8%12.2% (7)10.8%6.4% (7)6.2%3.1% (7)
FY202513.5%13.2% (7)12.2%8.8% (7)22.0%5.5% (7)

Peer medians use only peer-years that passed the same checks; a median of fewer than two companies is not shown. Years are grouped by financial-year label, and year-end months differ between companies.

Not yet available: where the cash goes (operating cash flow to capex, dividends and debt) and underlying versus reported earnings. The figures they need are not yet validated.

Years not charted

These years are on file but their figures did not pass the checks, so no chart is drawn for them.

  • FY2019: EBIT is -$1.7m. This layout does not draw an operating loss.
  • FY2018: EBITDA is -$2.3m. This layout draws revenue flowing into profit and does not draw an operating loss.
  • FY2017: EBITDA is -$0.4m. This layout draws revenue flowing into profit and does not draw an operating loss.
  • FY2016: EBITDA is -$0.4m. This layout draws revenue flowing into profit and does not draw an operating loss.
  • FY2015: Figures were not read from a filed annual report (source: not recorded).

All companies with a chart

Data sourced from NZX company annual reports (income statements). Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz.

For informational purposes only. Not investment advice.

Get NZX governance insights in your inbox

Weekly digest of board changes, insider trades, and market signals. No spam. Unsubscribe anytime.